8-KRegulation FDExhibits & Filings

AXON ENTERPRISE, INC. 8-K Report, Regulation FD Disclosure (Oct 29, 2019)

Filed October 29, 2019For Securities:AXON

Summary

Axon Enterprise, Inc. (AXON) filed an 8-K on October 29, 2019, primarily to disclose a production target for its TASER 7 units. During a Q&A session with analysts and investors at the International Association of Chiefs of Police annual conference, the company stated it expects to ship approximately 65,000 TASER 7 units by the end of the 2019 fiscal year. It is important for investors to note that this 65,000 figure represents a production target, and the actual number of units sold will be lower than this production volume. The company intends to provide more detailed shipment expectations for fiscal year 2019 when it announces its third-quarter financial results on November 7, 2019. This disclosure provides forward-looking information regarding a key product for Axon. While the production target offers a potential scale of manufacturing, the clarification that actual sales will be a subset is crucial for setting realistic investor expectations. The upcoming Q3 earnings call will be a critical event for investors seeking concrete sales figures and updated guidance, especially concerning the TASER 7 product line and its contribution to revenue.

Key Highlights

  • 1Axon announced a production target of approximately 65,000 TASER 7 units for the year ending December 31, 2019.
  • 2The company clarified that the 65,000 figure is a production target, and actual units sold will be less than this number.
  • 3This disclosure was made during a product-focused Q&A session at the International Association of Chiefs of Police annual conference.
  • 4Investors will receive updated shipment expectations for fiscal year 2019 during the Q3 financial results announcement on November 7, 2019.
  • 5The information is provided under Regulation FD Disclosure (Item 7.01) and is not deemed 'filed' for Section 18 purposes.
  • 6No new financial statements or exhibits were filed with this report (Item 9.01).

Frequently Asked Questions